showed that in 40 lung cancer patients, although CXCL9 was highly upregulated in tumor tissues, no significant relationship between CXCL9 expression and DFS or lower risk of postsurgical recurrence was observed 78. This evidence concerns the gene CXCL9 and lung cancer.